Cerebral toxoplasmosis (AIDS)
Opportunistic CNS · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Reactivation of Toxoplasma gondii in advanced HIV (CD4 <100), causing focal encephalitis with headache, focal deficits, seizures and typically multiple ring-enhancing brain lesions.
Red flags
- Reduced consciousness or rapidly progressive deficit
- Signs of raised ICP/herniation
- Status epilepticus
Assessment
Differential diagnosis
- Primary CNS lymphoma
- Progressive multifocal leukoencephalopathy
- Tuberculoma
- Cryptococcoma
- Brain abscess (bacterial)
Investigations
- Contrast CT/MRI brain (multiple ring-enhancing lesions, basal ganglia)
- Serum Toxoplasma IgG (usually positive)
- HIV test and CD4 count
- Consider brain biopsy if no response to empirical therapy
- LP if safe (to exclude other causes)
Management
- Start empirical anti-toxoplasma therapy and reassess clinically/radiologically at ~2 weeks
- Add folinic acid to reduce marrow toxicity of pyrimethamine
- Manage seizures and raised ICP; steroids only if significant mass effect/oedema
- Optimise HIV care and plan ART
- If no radiological improvement by 2 weeks, pursue biopsy for lymphoma/other
Drugs & doses
Pyrimethamine plus sulfadiazine plus folinic acid (first line)
Co-trimoxazole as alternative
Anticonvulsants for seizures
Dexamethasone only for significant mass effect
Disposition
Admit; HIV/infectious diseases and neurology involvement; follow-up imaging.
Complications & pitfalls
- Raised ICP and herniation
- Permanent neurological deficit
- Drug toxicity (marrow suppression, rash)
- IRIS
Exam pearls
- A positive Toxoplasma IgG plus multiple ring-enhancing lesions in advanced HIV supports empirical treatment.
- Failure to improve on empirical therapy by ~2 weeks shifts suspicion toward CNS lymphoma.
- Reserve steroids for mass effect - they confound response assessment.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.